These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 10703506)

  • 1. [Polychemotherapy-induced changes in the antioxidant state of blood in patients with inoperable cancer of the stomach].
    Frantsiiants EM; Orlovskaia LA; Shalashnaia EV; Mucienko NV; Anapalian BKh
    Vopr Onkol; 1999; 45(6):607-11. PubMed ID: 10703506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of therapy on the antioxidant status in patients with melanoma.
    Gadjeva V; Dimov A; Georgieva N
    J Clin Pharm Ther; 2008 Apr; 33(2):179-85. PubMed ID: 18315784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [TS-1/CDDP/Lentinan combination chemotherapy for inoperable advanced gastric cancer].
    Nagahashi S; Suzuki H; Nishiwaki M; Okuda K; Kurosawa Y; Terada S; Sugihara T; Andou K; Hibi T
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):1999-2003. PubMed ID: 15570928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of homolymph on some elements of antioxidants in peripheral blood of lung cancer patients].
    Sidorenko IuS; Frantsiiants EM; Musienko NV; Tkacheva GN; Shalashnaia EV; Kartashov SZ; Kas'ian EG
    Vopr Onkol; 1999; 45(3):241-4. PubMed ID: 10443223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of chemoradiotherapy with S-1 and low-dose cisplatin for inoperable advanced gastric cancer.
    Saikawa Y; Kubota T; Kumagai K; Nakamura R; Kumai K; Shigematsu N; Kubo A; Kitajima M; Kitagawa Y
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):173-9. PubMed ID: 17996385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The use of ceruloplasmin in combination with adjuvant polychemotherapy in stomach cancer].
    Shchepotin IB; Chernyĭ VA; Berdinskikh NK; Sanina OL; Baraboĭ VA; Starosel'skiĭ IV; Korobko VB; Kamenets LIa; Iaremenko LIa
    Vrach Delo; 1991 Mar; (3):24-7. PubMed ID: 2042339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatic and non-enzymatic antioxidant status in stage (III) human oral squamous cell carcinoma and treated with radical radio therapy: influence of selenium supplementation.
    Elango N; Samuel S; Chinnakkannu P
    Clin Chim Acta; 2006 Nov; 373(1-2):92-8. PubMed ID: 16831410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of autolymph on peripheral blood antioxidants in lung cancer patients].
    Sidorenko IuS; Frantsiiants EM; Musienko NV; Tkacheva GN; Shalashnaia EV; Kartashov SZ; Kas'ian EG
    Vopr Onkol; 1999; 45(3):245-8. PubMed ID: 10443224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical profile of carcinoma stomach at a tertiary care hospital in south India.
    Sambasivaiah K; Ibrarullah M; Reddy MK; Reddy PV; Wagholikar G; Jaiman S; Reddy DG; Sarma KV; Hegde GN
    Trop Gastroenterol; 2004; 25(1):21-6. PubMed ID: 15303466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlative analysis between serum dihydropyrimidine dehydrogenase, activity, concentration of 5-fluorouracil and adverse events in the treatment of advanced gastric cancer patients].
    Peng RJ; Dong QM; Shi YX; Cao Y; Zhou ZM; Yuan ZY; Li S; Li H; Jiang WQ
    Ai Zheng; 2006 Aug; 25(8):1039-43. PubMed ID: 16965690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of advanced gastric cancer by chemotherapy combined with autologous cytokine-induced killer cells.
    Jiang J; Xu N; Wu C; Deng H; Lu M; Li M; Xu B; Wu J; Wang R; Xu J; Nilsson-Ehle P
    Anticancer Res; 2006; 26(3B):2237-42. PubMed ID: 16821594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Specific changes in the parameters of blood antioxidant status in patients with cervical carcinoma in the course of cancer therapyĭ].
    Rozenko LIa; Sidorenko IuS; Frantsiiants EM
    Vopr Onkol; 1999; 45(6):630-5. PubMed ID: 10703511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [TS-1/CDDP therapy for advanced gastric cancer as neoadjuvant chemotherapy].
    Nakamura M; Maruyama K; Furukawa J; Maruyama N; Tanaka J; Katsumoto Y; Yokouchi H; Nakaguchi K; Sue F; Yoshihara W
    Gan To Kagaku Ryoho; 2002 Oct; 29(10):1823-8. PubMed ID: 12402437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significances of oxidative DNA damage evaluated by 8-hydroxy-deoxyguanosine and antioxidant enzymes in patients undergoing resection of gastric and colon carcinoma.
    Dincer Y; Himmetoglu S; Akcay T; Ersoy EY; Gunes KN; Tortum O
    Neoplasma; 2007; 54(2):131-6. PubMed ID: 17319786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent decline of several antioxidants and markers of oxidative stress during combination chemotherapy for small cell lung cancer.
    Crohns M; Liippo K; Erhola M; Kankaanranta H; Moilanen E; Alho H; Kellokumpu-Lehtinen P
    Clin Biochem; 2009 Aug; 42(12):1236-45. PubMed ID: 19445914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of weekly paclitaxel plus 5-fluorouracil and cisplatin for patients with advanced or recurrent inoperable gastric cancer.
    Gu Y; Shu Y; Xu Q
    Biomed Pharmacother; 2009 May; 63(4):293-6. PubMed ID: 18848761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Three advanced gastric cancer patients successfully treated by combination therapy of paclitaxel and cisplatin].
    Yamada T; Tanaka N; Yokoi K; Ishikawa N; Seya T; Horiba K; Kanazawa Y; Shirakawa T; Ohkawa K; Kudoh H; Koizumi M; Yoshioka M; Shinji S; Katsuta M; Yamashita K; Tajiri T
    Gan To Kagaku Ryoho; 2007 May; 34(5):769-72. PubMed ID: 17496455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of fractionated low dose Cisplatin on renal functions of patients with gastric carcinoma].
    Li Y; Shen L; Li J; Jin ML
    Ai Zheng; 2007 Dec; 26(12):1354-6. PubMed ID: 18076800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effectiveness of S-1 based sequential chemotherapy as second-line treatment for advanced/recurrent gastric cancer].
    Sugimoto N; Narahara H; Sakai D; Yamamoto S; Fumoto S; Yagi T; Imamura F; Iishi H; Tatsuta M
    Gan To Kagaku Ryoho; 2009 Mar; 36(3):417-24. PubMed ID: 19295265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The clinical effect of low-dose FP (5-FU + low-dose CDDP) in patients with far advanced gastric cancer, and their quality of life].
    Murakami S; Yoshida K; Kin R; Nishimoto N; Kagawa Y; Yano Y; Nishiyama M; Hirai T; Toge T
    Gan To Kagaku Ryoho; 2000 Jun; 27(6):853-8. PubMed ID: 10897211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.